RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Kissei Pharmaceutical Co Stock

Kissei Pharmaceutical Co Equity 2024

Kissei Pharmaceutical Co Equity

220.03 B JPY

Ticker

4547.T

ISIN

JP3240600001

WKN

881370

In 2024, Kissei Pharmaceutical Co's equity was 220.03 B JPY, a 9.26% increase from the 201.39 B JPY equity in the previous year.

Kissei Pharmaceutical Co Aktienanalyse

What does Kissei Pharmaceutical Co do?

Kissei Pharmaceutical Co., Ltd. is a leading innovative company in Japan that focuses on the development and production of pharmaceuticals for various diseases. The Kissei Group consists of several companies that work together in the development and production of pharmaceuticals and other medical products. History: Kissei Pharmaceutical was founded in 1946 in Matsumoto, Japan. The company initially manufactured drugs for skin and respiratory diseases and later expanded its portfolio to include drugs for cancer and Parkinson's. Over time, Kissei Pharmaceutical has also invested in research and development and has become a key player in the global pharmaceutical industry. Business model: Kissei Pharmaceutical's business model is based on the development and marketing of innovative drugs for various diseases. The company's strategy is to focus on niche markets and invest in research and development to develop groundbreaking drugs. The company also seeks partnerships and has a strong presence in the Asian market. Divisions: Kissei Pharmaceutical is divided into various business areas, including cancer, neurological disorders, metabolic disorders, and dermatological diseases. The largest business area is oncology, where the company offers many products for the treatment of cancer. The neurology division includes products for the treatment of Parkinson's and Alzheimer's. In the field of metabolic disorders, Kissei Pharmaceutical offers drugs for the treatment of diabetes and obesity. In dermatology, the products include skincare products for various skin conditions such as eczema and psoriasis. Products: Kissei Pharmaceutical offers a wide range of pharmaceutical products for a variety of diseases. In the field of oncology, the company produces drugs such as docetaxel for breast and lung cancer, and irinotecan for colon cancer. In the field of neurological disorders, Kissei Pharmaceutical produces drugs such as levodopa for Parkinson's, and TAK-659 for cancer patients with high blood sugar levels. In the field of metabolic disorders, the company produces drugs such as insulin for the treatment of diabetes, and leptin for the treatment of obesity. In dermatology, Kissei Pharmaceutical produces drugs such as epicederm for eczema and psoriasis, and apimo for acne. Conclusion: Kissei Pharmaceutical is an innovative company in Japan that specializes in the development and production of pharmaceuticals for various diseases. The company has a strong presence in the Asian market and works closely with partners to develop new drugs. With its various business divisions and wide range of products, Kissei Pharmaceutical is a key player in the global pharmaceutical industry. Kissei Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Kissei Pharmaceutical Co's Equity

Kissei Pharmaceutical Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Kissei Pharmaceutical Co's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Kissei Pharmaceutical Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Kissei Pharmaceutical Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Kissei Pharmaceutical Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Kissei Pharmaceutical Co stock

What is the equity of Kissei Pharmaceutical Co this year?

Kissei Pharmaceutical Co has equity of 220.03 B JPY this year.

What was the equity of Kissei Pharmaceutical Co compared to the previous year?

The equity of Kissei Pharmaceutical Co has increased/decreased by 9.26% increased compared to the previous year.

What impact does a high equity have on investors of Kissei Pharmaceutical Co?

A high equity is advantageous for investors of Kissei Pharmaceutical Co as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Kissei Pharmaceutical Co?

A low equity can be a risk for investors of Kissei Pharmaceutical Co, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Kissei Pharmaceutical Co affect the company?

An increase in equity of Kissei Pharmaceutical Co can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Kissei Pharmaceutical Co affect the company?

A reduction in equity of Kissei Pharmaceutical Co can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Kissei Pharmaceutical Co?

Some factors that can affect the equity of Kissei Pharmaceutical Co include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Kissei Pharmaceutical Co so important for investors?

The equity of Kissei Pharmaceutical Co is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Kissei Pharmaceutical Co take to change the equity?

To change equity, Kissei Pharmaceutical Co can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Kissei Pharmaceutical Co pay?

Over the past 12 months, Kissei Pharmaceutical Co paid a dividend of 86 JPY . This corresponds to a dividend yield of about 2.61 %. For the coming 12 months, Kissei Pharmaceutical Co is expected to pay a dividend of 89.31 JPY.

What is the dividend yield of Kissei Pharmaceutical Co?

The current dividend yield of Kissei Pharmaceutical Co is 2.61 %.

When does Kissei Pharmaceutical Co pay dividends?

Kissei Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of October, April, October, April.

How secure is the dividend of Kissei Pharmaceutical Co?

Kissei Pharmaceutical Co paid dividends every year for the past 23 years.

What is the dividend of Kissei Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 89.31 JPY are expected. This corresponds to a dividend yield of 2.71 %.

In which sector is Kissei Pharmaceutical Co located?

Kissei Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Kissei Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Kissei Pharmaceutical Co from 12/1/2024 amounting to 45 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did Kissei Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 12/1/2024.

What was the dividend of Kissei Pharmaceutical Co in the year 2023?

In the year 2023, Kissei Pharmaceutical Co distributed 81 JPY as dividends.

In which currency does Kissei Pharmaceutical Co pay out the dividend?

The dividends of Kissei Pharmaceutical Co are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Kissei Pharmaceutical Co

Our stock analysis for Kissei Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Kissei Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.